Insightec

This early-stage study tests whether a focused ultrasound technique can safely open the blood-brain barrier to deliver a Parkinson's drug directly to a key brain area. Fourteen participants with mild to moderate Parkinson's will receive the treatment. The main goal is to check sa…

This study tracks people with advanced Parkinson's disease who receive a treatment called Exablate, which uses focused ultrasound to target a small area in the brain. The goal is to see how well it reduces medication-resistant motor problems like shaking and stiffness. Researcher…

This study tests a device that uses focused sound waves to temporarily open the blood-brain barrier in people with Alzheimer's disease. The goal is to see if this is safe and can help treatments work better. About 50 adults aged 50-85 with probable Alzheimer's will take part.

This study is testing a device called ExAblate 4000 that uses focused ultrasound waves to destroy benign brain tumors without cutting into the skull. It includes 20 children and young adults with non-cancerous, centrally located brain tumors that need treatment. The main goals ar…

This study is a registry that follows people with tremor-dominant Parkinson's disease who have already chosen to receive a treatment called Exablate thalamotomy. The treatment uses focused ultrasound to target a small area in the brain to reduce tremors. The goal is to collect lo…

This early study tests whether low-intensity focused ultrasound (LIFU) can safely help people with opioid or other substance use disorders. Researchers will treat 29 adults who are already in outpatient addiction programs. The main goal is to see if the procedure is well-tolerate…